Verve Therapeutics, Inc. (VERV) NASDAQ

11.14

-0.243(-2.14%)

Updated at June 18 02:12PM

Currency In USD

Valuation

Market Cap477.83M
Enterprise Value375.26M
P/E Ratio-5.35
PEG Ratio-0.55
Price/Sales Ratio16.68
Price/Book Ratio2.05
Enterprise/Revenue16.21
Enterprise/EBITDA-4.75

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-3.04
Operating Margin-3.5

Management Effectiveness

Return On Assets-0.29
Return On Equity-0.36

Income Statement

Revenue32.33M
Revenue/Share0.69
Gross Profit32.33M
EBITDA-221.91M
Net Income-198.71M
Diluted EPS-2.35

Balance Sheet

Total Cash497.08M
Total Cash/Share5.72
Total Debt68.64M
Total Debt/Equity0.14
Current Ratio9.84
Book Value Per Share5.45

Price History

52-Week Change118.82
52-Week High11.41
52-Week Low2.87
Moving Average 50 Days4.97
Moving Average 200 Days5.74

Statistics

Average Volume4.81M
Shares Outstanding89.14M
% Held by Institutions92.94

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A